Andrea Newkirk
Stock Analyst at Goldman Sachs
(3.00)
# 1,295
Out of 5,182 analysts
4
Total ratings
100%
Success rate
89.71%
Average return
Main Sectors:
Stocks Rated by Andrea Newkirk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Initiates: Neutral | $19 | $11.52 | +64.93% | 1 | Sep 30, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $73 | $95.36 | -23.45% | 2 | Sep 12, 2025 | |
| ALKS Alkermes | Initiates: Buy | $43 | $34.08 | +26.17% | 1 | Jul 15, 2025 |
Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $11.52
Upside: +64.93%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65 → $73
Current: $95.36
Upside: -23.45%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $34.08
Upside: +26.17%